[TENAGA] QoQ TTM Result on 31-Aug-2014 [#4]

Announcement Date
31-Oct-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Aug-2014
Quarter
31-Aug-2014 [#4]
Profit Trend
QoQ- 7.09%
YoY- 21.22%
View:
Show?
TTM Result
31/05/15 28/02/15 30/11/14 31/08/14 31/05/14 28/02/14 30/11/13 CAGR
Revenue 43,266,200 44,860,400 44,247,100 42,792,400 40,571,900 38,719,500 37,573,000 9.87%
PBT 8,031,000 9,166,200 8,118,900 7,114,700 5,033,400 5,220,000 5,506,800 28.63%
Tax -1,457,700 -1,720,400 -1,073,500 -687,900 988,300 919,300 160,700 -
NP 6,573,300 7,445,800 7,045,400 6,426,800 6,021,700 6,139,300 5,667,500 10.39%
-
NP to SH 6,653,400 7,490,900 7,068,600 6,467,000 6,039,000 6,131,500 5,669,700 11.26%
-
Tax Rate 18.15% 18.77% 13.22% 9.67% -19.63% -17.61% -2.92% -
Total Cost 36,692,900 37,414,600 37,201,700 36,365,600 34,550,200 32,580,200 31,905,500 9.77%
-
Net Worth 46,721,307 46,701,679 45,604,398 43,216,136 33,860,112 33,864,819 36,848,281 17.16%
Dividend
31/05/15 28/02/15 30/11/14 31/08/14 31/05/14 28/02/14 30/11/13 CAGR
Div 1,636,383 1,636,383 1,636,494 1,636,494 1,399,692 1,399,692 1,386,927 11.66%
Div Payout % 24.59% 21.84% 23.15% 25.31% 23.18% 22.83% 24.46% -
Equity
31/05/15 28/02/15 30/11/14 31/08/14 31/05/14 28/02/14 30/11/13 CAGR
Net Worth 46,721,307 46,701,679 45,604,398 43,216,136 33,860,112 33,864,819 36,848,281 17.16%
NOSH 5,642,601 5,643,025 5,644,108 5,642,530 5,643,352 5,644,136 5,643,786 -0.01%
Ratio Analysis
31/05/15 28/02/15 30/11/14 31/08/14 31/05/14 28/02/14 30/11/13 CAGR
NP Margin 15.19% 16.60% 15.92% 15.02% 14.84% 15.86% 15.08% -
ROE 14.24% 16.04% 15.50% 14.96% 17.84% 18.11% 15.39% -
Per Share
31/05/15 28/02/15 30/11/14 31/08/14 31/05/14 28/02/14 30/11/13 CAGR
RPS 766.78 794.97 783.95 758.39 718.93 686.01 665.74 9.88%
EPS 117.91 132.75 125.24 114.61 107.01 108.63 100.46 11.27%
DPS 29.00 29.00 29.00 29.00 25.00 25.00 24.57 11.69%
NAPS 8.2801 8.276 8.08 7.659 6.00 6.00 6.529 17.18%
Adjusted Per Share Value based on latest NOSH - 5,642,530
31/05/15 28/02/15 30/11/14 31/08/14 31/05/14 28/02/14 30/11/13 CAGR
RPS 744.31 771.73 761.18 736.16 697.96 666.09 646.37 9.87%
EPS 114.46 128.87 121.60 111.25 103.89 105.48 97.54 11.26%
DPS 28.15 28.15 28.15 28.15 24.08 24.08 23.86 11.66%
NAPS 8.0375 8.0341 7.8453 7.4345 5.8249 5.8258 6.339 17.16%
Price Multiplier on Financial Quarter End Date
31/05/15 28/02/15 30/11/14 31/08/14 31/05/14 28/02/14 30/11/13 CAGR
Date 29/05/15 27/02/15 28/11/14 29/08/14 30/05/14 28/02/14 29/11/13 -
Price 13.36 14.72 14.26 12.38 12.06 12.00 9.86 -
P/RPS 1.74 1.85 1.82 1.63 1.68 1.75 1.48 11.40%
P/EPS 11.33 11.09 11.39 10.80 11.27 11.05 9.81 10.08%
EY 8.83 9.02 8.78 9.26 8.87 9.05 10.19 -9.11%
DY 2.17 1.97 2.03 2.34 2.07 2.08 2.49 -8.77%
P/NAPS 1.61 1.78 1.76 1.62 2.01 2.00 1.51 4.37%
Price Multiplier on Announcement Date
31/05/15 28/02/15 30/11/14 31/08/14 31/05/14 28/02/14 30/11/13 CAGR
Date 30/07/15 27/04/15 22/01/15 31/10/14 16/07/14 24/04/14 23/01/14 -
Price 12.12 14.60 14.52 13.36 12.46 11.94 11.50 -
P/RPS 1.58 1.84 1.85 1.76 1.73 1.74 1.73 -5.87%
P/EPS 10.28 11.00 11.59 11.66 11.64 10.99 11.45 -6.93%
EY 9.73 9.09 8.63 8.58 8.59 9.10 8.74 7.42%
DY 2.39 1.99 2.00 2.17 2.01 2.09 2.14 7.65%
P/NAPS 1.46 1.76 1.80 1.74 2.08 1.99 1.76 -11.72%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment